Seracare Life Sciences Inc Com Stk (SRLS) Cash Flow Statement

Click line-items for a historical chart and %

Net income	1.01M
Depreciation and amortization	321.73K
Amortization of deferred financing expenses	45.13K
Bad debt expense (recoveries), net
Write-down of inventory	196.76K
Loss on disposal of property and equipment	-1.2K
Gain on disposition of certain assets of Genomics Collaborative division	0
Stock-based compensation	244.47K
Accounts receivable	-378.19K
Taxes receivable
Inventory	-712.56K
Prepaid expenses and other current assets	-89.6K
Other assets	18.93K
Accounts payable	236.1K
Accrued expenses and other liabilities
Net cash provided by operating activities	1.09M
Purchases of property and equipment	-142.66K
Proceeds from the sale of assets held for sale, net
Proceeds from the disposition of certain assets of Genomics Collaborative division	0
Net cash (used in) provided by investing activities	-141.46K
Repayments of long-term debt	-5.95K
Deferred financing expenses	0
Proceeds from exercise of options	495.5K
Net cash used in financing activities	430.99K
Net increase in cash and cash equivalents	1.38M
Cash and cash equivalents, beginning of period	18.11M
Cash and cash equivalents, end of period	19.49M

Entities mentioned with SRLS

View All Entities